Transcription-histone methylation |
H4 |
R3me2a |
PRMT1 |
Transcription activation |
140,141 |
|
|
PRMT3 |
Transcription activation |
142 |
|
R3me2s |
PRMT5 |
Transcription repression |
143–145 |
H3 |
R2me2a |
PRMT6 |
Transcription repression |
146,147 |
|
R2me2s |
PRMT5 |
Transcription activation |
79 |
|
R8me2a |
PRMT2 |
Transcription activation |
148 |
|
R8me2s |
PRMT5 |
Transcription repression |
97,149 |
|
R17/R26me2a |
CARM1 |
Transcription activation |
150–152 |
|
R42me2a |
CARM1/PRMT6 |
Transcription activation |
153 |
H2A |
R29me2a |
PRMT6 |
Transcription repression |
154 |
Transcription–transcription factors |
STAT1 |
R31 |
PRMT1 |
Activates STAT1 transactivity |
155 |
C/EBPα |
R35/156/165 |
PRMT1 |
Blocks the interaction with its corepressor, HDAC3 |
156 |
RUNX1 |
R206/210 |
PRMT1 |
Interferes with binding to SIN3A |
157 |
FOXO1 |
R248/250 |
PRMT1 |
Stabilizes the FOXO1 protein |
158 |
MyoD |
R121 |
PRMT1 |
Increases MyoD transactivity |
159 |
Nrf2 |
R437 |
PRMT1 |
Increases DNA-binding affinity and transactivity |
160 |
Twist1 |
R34 |
PRMT1 |
Facilitates repressive activity at the E-cadherin promoter |
68 |
p65/RelA |
R30 |
PRMT1 |
Inhibits its own DNA-binding affinity |
161 |
GLI1 |
R597 |
PRMT1 |
Enhances the recruitment of GLI1 to target gene promoters |
67 |
CBP/p300 |
R714/742/768/2104/2151 |
CARM1 |
Enhances the HAT activity of CBP/p300 |
162–165 |
Sox2 |
R113 |
CARM1 |
Increases Sox2 transactivity |
166 |
FoxO3 |
— |
CARM1 |
Increases FoxO3 transactivity |
167 |
Sox9 |
— |
CARM1 |
Disrupts the binding between Sox9 and β-catenin |
168 |
MED12 |
R1862/1912 |
CARM1 |
Suppresses p21WAF1 transcription |
75 |
p65/RelA |
R30 |
PRMT5 |
Enhances the transactivation of NF-κB |
169 |
p64/RelA |
R174 |
PRMT5 |
Increases TNF-α/IFN-γ-induced CXCL11 gene expression |
170 |
GLI1 |
R990/1018 |
PRMT5 |
Promotes proteasome-dependent degradation of GLI1 |
171 |
HOXA9 |
R140 |
PRMT5 |
Increases transactivation of HOXA9 in the E-selectin promoter |
172 |
GLI2 |
R225/227 |
PRMT7 |
Dissociates GLI2 from SUFU |
173 |
mRNA splicing/alternative splicing |
Sm D1, D3, B/B' |
SDMA |
PRMT5 |
Enhances binding with SMN |
26,174–176 |
SmB/B’ |
ADMA |
CARM1 |
Unknown |
177,178 |
CA150 |
|
CARM1 |
Enhances binding with SMN |
178 |
LSm4 |
|
PRMT5 |
Promotes interaction with HAT1-RBBP7 |
179,180 |
Coilin |
|
PRMT5 |
Mediates SMN localization in the Cajal body |
28,181 |
fibrillarin |
|
PRMT1 |
Facilitates interaction with SMN |
182 |
GAR1 |
|
PRMT1 |
Facilitates interaction with SMN |
182 |
hnRNP A2 |
|
PRMT1 |
Regulates cytosolic/nucleus localization |
183 |
hnRNAP Q |
|
PRMT1 |
Regulates cytosolic/nucleus localization |
184 |
hnRNP K |
|
PRMT1 |
Promotes the interaction with c-Src |
185 |
RBM15 |
R578 |
PRMT1 |
Promotes ubiquitination by E3 ligase CNOT4 |
186 |
KSRP |
|
CARM1 |
Enhances interaction with SMN |
187 |
ZNF326 |
R175 |
PRMT5 |
Regulates alternative splicing process |
188 |
SAP145 |
R508 |
PRMT9 |
Promotes interaction with SMN and U2 snRNP maturation |
189,190 |
Translation |
AVEN |
|
PRMT1 |
Regulates translation in G-quadruplexes harboring mRNA |
191 |
TOP3B |
R833/835 |
PRMT1/3/6 |
Localizes to stress granules |
192 |
rpS3 |
R64/65/67 |
PRMT1 |
Promotes ribosome assembly |
193 |
rpS2 |
|
PRMT3 |
Inhibits ubiquitin-dependent degradation of rpS2 |
194,195 |
PABP1 |
|
CARM1 |
Unknown |
196 |
hnRNP A1 |
R218 |
PRMT5 |
Controls IRES-dependent translation |
197 |
RPS10 |
R158/160 |
PRMT5 |
Regulates the assembly of ribosomes |
198 |
eIF2a |
R54 |
PRMT7 |
Regulates stress granule formation |
199 |
Cell signaling |
EGFR |
R1175 |
PRMT5 |
Promotes association with SHP1 phosphatase |
200 |
|
R198/200 |
PRMT1 |
Increases binding affinity for EGF leading to dimerization of EGFR |
66 |
CRAF |
R563 |
PRMT5 |
Regulates degradation of CRAF |
201 |
|
R100 |
PRMT6 |
Regulates the binding affinity for RAS |
202 |
p38 MAPK |
R70 |
PRMT7 |
Enhances p38 MAPK activation |
203 |
ASK1 |
R78/80 |
PRMT1 |
Promotes the association with thioredoxin |
204 |
|
R89 |
PRMT5 |
Promotes AKT-mediated Ser83 phosphorylation of ASK1 |
205 |
Smad6 |
R74 |
PRMT1 |
Facilitates the dissociation of Smad6 from type I receptors |
135 |
Smad7 |
R57/67 |
PRMT1 |
Facilitates the dissociation of Smad7 from type I receptors |
134 |
Cell cycle |
CDK4 |
R55/73/82/163 |
PRMT1 |
Inhibits CDK-Cyclin D3 complex formation |
31 |
INCENP |
R887 |
PRMT1 |
Facilitates interaction with AURKB |
32 |
UBAP2L |
RGG/RG motif |
PRMT1 |
Promotes alignment of chromosomes in metaphase |
33 |
H3 |
R2me2a |
PRMT6 |
Recruits AURKB/CPC to chromosome arm during mitosis |
43 |
DNA damage response |
MRE11 |
GAR motif |
PRMT1 |
Activates exonuclease activity and recruits factors to damaged DNA |
44,45 |
53BP1 |
GAR motif |
PRMT1 |
Increases DNA-binding affinity |
47,48 |
|
|
PRMT5 |
Stabilizes the 53BP1 protein |
63 |
DNA polymerase β |
R137 |
PRMT1 |
Interferes with binding with PCNA |
50 |
FEN1 |
R192 |
PRMT1 |
Interaction with PCNA and localization to damaged DNA foci |
51 |
Rad9 |
R172/174/175 |
PRMT5 |
Activation of CHK1 signaling |
55 |
p53 |
R333/335/337 |
PRMT5 |
Regulation of promoter selectivity |
57,58 |
E2F1 |
R111/113 |
PRMT5 |
Downregulation of E2F1 protein stability |
59,206 |
KLF4 |
R374/376/377 |
PRMT5 |
Inhibition of VHL-mediated ubiquitination |
60 |
RUVBL1 |
R205 |
PRMT5 |
Increase in TIP60-dependent chromosome acetylation |
61 |
p300/CBP |
R754 |
CARM1 |
Recognition by BRCA1 and p21WAF1 induction |
54 |